Renal physiology

Global Serotonin Creatinine Sulfate (CAS 61-47-2) Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 1, 2021
Chemicals, Plastics, Pharmaceutical, Health, Manufacturing, Branches of biology, Psychoactive drugs, Drugs, TAAR1 agonists, Guanidines, Renal physiology, Euphoriants, Stimulants, Creatinine, Sulfate, MDMA, Creatine

The "Serotonin creatinine sulfate (CAS 61-47-2) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Serotonin creatinine sulfate (CAS 61-47-2) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Serotonin creatinine sulfate.
  • The fifth chapter deals with Serotonin creatinine sulfate market trends and forecast, distinguish Serotonin creatinine sulfate manufacturers and suppliers.
  • The Serotonin creatinine sulfate global market report key points:

World Diabetic Nephropathy Disease Analysis Report 2021: Probability of Success, Drug Assessment, Regulatory Events, Key Upcoming Events, Unmet Needs, Epidemiology, Treatment

Retrieved on: 
Wednesday, March 24, 2021
Medical specialties, Kidney diseases, Organ systems, Anatomy, Diabetes, Diabetic nephropathy, Blood tests, Renal physiology, Albuminuria, Glomerular filtration rate, Kidney, Hypertensive kidney disease

DUBLIN, March 24, 2021 /PRNewswire/ -- The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 24, 2021 /PRNewswire/ -- The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering.
  • Diabetic nephropathy, also known as diabetic kidney disease, is caused by damage to small blood vessels which can cause the kidneys to be less efficient in their blood filtration role or to fail altogether.
  • The disease is a clinical syndrome characterized by albuminuria, decline in glomerular filtration rate, and elevated arterial blood pressure.
  • Up to 50% of diabetics with a disease duration of over 20 years have diabetic nephropathy.

Global Diabetic Nephropathy Disease Analysis/Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 19, 2021
Diabetes, Pharmaceutical, Health, Medical specialties, Anatomy, Organ systems, Kidney diseases, Diabetes, Blood tests, Renal physiology, Diabetic nephropathy, Assessment of kidney function, Albuminuria, Glomerular filtration rate, Kidney

The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering.
  • Diabetic nephropathy, also known as diabetic kidney disease, is caused by damage to small blood vessels which can cause the kidneys to be less efficient in their blood filtration role or to fail altogether.
  • The disease is a clinical syndrome characterized by albuminuria, decline in glomerular filtration rate, and elevated arterial blood pressure.
  • Up to 50% of diabetics with a disease duration of over 20 years have diabetic nephropathy.

Global Creatinine Sulfate (CAS 31377-28-3) Market Report 2021: Trends and Developments, Major Players, Main Downstream Sectors, Market Prices - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 17, 2021
Chemicals, Plastics, Manufacturing, Renal physiology, Creatinine, Guanidines, Metabolism, Nephrology, Business process, Sulfate, Market research, Chemistry, Physical sciences, Chemical substances

The "Creatinine sulfate (CAS 31377-28-3) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Creatinine sulfate (CAS 31377-28-3) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Creatinine sulfate.
  • The report helps to build up a clear view of the market trends and development, identify major players in the industry, and estimate main downstream sectors.
  • The fifth chapter deals with Creatinine sulfate market trends and forecast, distinguish Creatinine sulfate manufacturers and suppliers.

Kidney Function Tests Market Size Worth $1.25 Billion By 2028 | CAGR 6.2%: Grand View Research, Inc.

Retrieved on: 
Wednesday, March 3, 2021
Branches of biology, Anatomy, Assessment of kidney function, Renal physiology, Kidney

SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- The global kidney function tests market size is expected to reach USD 1.25 billion by 2028 registering a CAGR of 6.2% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- The global kidney function tests market size is expected to reach USD 1.25 billion by 2028 registering a CAGR of 6.2% from 2021 to 2028, according to a new report by Grand View Research, Inc.
  • The introduction of innovative products, increasing R&D investments, and growing prevalence of kidney diseases are expected to propel market growth over the forecast period.
  • Key players operating in the market are involved in extensive R&D initiatives for the development and launch of novel products to strengthen their position in the market.
  • Grand View Research has segmented the global kidney function tests market on the basis of product, end-use, and region:
    Kidney Function Tests Product Outlook (Revenue, USD Million, 2016 - 2028)

Kidney Function Tests Market Size Worth $1.25 Billion By 2028 | CAGR 6.2%: Grand View Research, Inc.

Retrieved on: 
Wednesday, March 3, 2021
Branches of biology, Anatomy, Assessment of kidney function, Renal physiology, Kidney

SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- The global kidney function tests market size is expected to reach USD 1.25 billion by 2028 registering a CAGR of 6.2% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- The global kidney function tests market size is expected to reach USD 1.25 billion by 2028 registering a CAGR of 6.2% from 2021 to 2028, according to a new report by Grand View Research, Inc.
  • The introduction of innovative products, increasing R&D investments, and growing prevalence of kidney diseases are expected to propel market growth over the forecast period.
  • Key players operating in the market are involved in extensive R&D initiatives for the development and launch of novel products to strengthen their position in the market.
  • Grand View Research has segmented the global kidney function tests market on the basis of product, end-use, and region:
    Kidney Function Tests Product Outlook (Revenue, USD Million, 2016 - 2028)

The National Kidney Foundation Launches the First-Ever National Registry for All Stages of Kidney Disease

Retrieved on: 
Thursday, February 25, 2021
Medical specialties, Anatomy, Medicine, Kidney diseases, Organ failure, National Kidney Foundation, Chronic kidney disease, Nephrology, NKF, Blood tests, Renal physiology, National Kidney Foundation Singapore

NEW YORK, Feb. 25, 2021 /PRNewswire/ --Today the National Kidney Foundation (NKF) launched the first-ever national registry for patients at all stages of kidney disease, the NKF Patient Network .

Key Points: 
  • NEW YORK, Feb. 25, 2021 /PRNewswire/ --Today the National Kidney Foundation (NKF) launched the first-ever national registry for patients at all stages of kidney disease, the NKF Patient Network .
  • "The data collected goes beyond numbers on a spreadsheetwe want to hear about a patient's experience living with kidney disease.
  • This national launch is a great step forward in considering the diversity of the population with kidney disease.
  • In the United States, 37 million adults are estimated to have kidney disease, also called chronic kidney disease (CKD), and approximately 90 percent don't know they have it.

numares’ Novel GFR Equation Allows Accurate Assessment of Renal Insufficiency in Proof of Concept

Retrieved on: 
Thursday, February 25, 2021
Research, Technology, Venture capital, Clinical trials, Professional services, Biotechnology, Hardware, Health, Data management, Science, Anatomy, Branches of biology, Medical specialties, Renal physiology, Nephrology, Organ failure, Kidney diseases, Blood tests, Creatinine, Assessment of kidney function, Kidney, Chronic kidney disease

Named GFRNMR, the test provided metabolic characterization of renal dysfunction, by evaluating a group of metabolites.

Key Points: 
  • Named GFRNMR, the test provided metabolic characterization of renal dysfunction, by evaluating a group of metabolites.
  • The test holds the potential for an improved assessment of kidney function, and deeper insights into kidney pathophysiology.
  • Subsequent to this proof of concept, we have been able to further refine our metabolite-based modeling, using a much broader set of samples.
  • 1 Full article: Ehrich, J., et al., Serum myo-inositol, dimethyl sulfone, and valine in combination with creatinine allow accurate assessment of renal insufficiency.

GFR Fund Announces New Scout Fund, GFR Artists, Helping Young Companies Advance Productivity During COVID and Beyond

Retrieved on: 
Thursday, February 11, 2021
Renal physiology, Blood tests

GFR Artists was formed in July 2020 as a sub-fund of #GFR Fund II (formed in December 2018) and is led by @Teppei Tsutsui and @Nikhil Gopalani.

Key Points: 
  • GFR Artists was formed in July 2020 as a sub-fund of #GFR Fund II (formed in December 2018) and is led by @Teppei Tsutsui and @Nikhil Gopalani.
  • To date, GFR Artists has invested in 16 companies and plans to invest in ten more before the fund closes.
  • Nikhil Gopalani, Venture Partner at GFR Fund & Co-founder of GFR Artists has been an early-stage investor for the past seven years in more than 40 companies.
  • To date, GFR Fund has invested in 47 companies, including ProGuides, RTFKT, Fan.AI, VRChat, WaveXR, Theta.tv, Littlstar, Fable, YBVR, Sturfee, Resolve, Samba.tv, Apprentice.io and Phiar.

National Kidney Foundation Launches New Pediatric Risk Calculator

Retrieved on: 
Tuesday, February 9, 2021
Anatomy, Medical specialties, Organ failure, Branches of biology, National Kidney Foundation, Nephrology, NKF, Kidney failure, Chronic kidney disease, Blood tests, Renal physiology, National Kidney Foundation Singapore

NEW YORK, Feb. 9, 2021 /PRNewswire/ --Today, the National Kidney Foundation (NKF) unveiled a new clinical tool for pediatric healthcare professionals to assess kidney disease progression in children and help provide more targeted care.

Key Points: 
  • NEW YORK, Feb. 9, 2021 /PRNewswire/ --Today, the National Kidney Foundation (NKF) unveiled a new clinical tool for pediatric healthcare professionals to assess kidney disease progression in children and help provide more targeted care.
  • Identifying and managing kidney disease, also known as chronic kidney disease (CKD), in the early stages give patients the best chance at postponing or avoiding life-threatening kidney failure.
  • "I am very pleased that the National Kidney Foundation is making the Pediatric Kidney Failure Risk Calculator widely available to healthcare professionals," Dr. Warady said.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .